Unfortunately, the odds of getting to the venue on time were definitely not in my favour this time around. Having to deal with the general chaos that is London traffic, as well as some ...

The phase 3 comeback story Bristol Myers Squibb investors were eagerly anticipating is not to be—at least not this year. The highly anticipated Adept-2 study will not read out by year-end as ...

Bristol Myers Squibb (NYSE: BMY, “BMS”) today announced that it will enroll additional patients in the ADEPT-2 study. As part of its commitment to upholding the highest standards in clinical research ...

Analysts had noted “unease” from investors regarding the state of the Phase III ADEPT-2 trial, with BMS at one point telling Leerink Partners that the reopening of enrollment would be a “significant ...

KYOTO, Japan--(BUSINESS WIRE)--OMRON (TOKYO: 6645) has announced its “Medium-Term Roadmap Shaping the Future 2nd Stage (“SF 2nd Stage”),” covering from FY2026 to FY2030, on November 7, 2025 (JST).

Echo Re has begun using ACORD Solutions Group’s ADEPT platform to receive digital accounting and claims messages from Gallagher Re, streamlining communication by eliminating manual downloads and ...

New Jersey, United States,- The research study presented here is an intelligent take on the Articulated Robot Market that explains important aspects such as competition, segmentation, and regional ...

KYOTO, Japan, Oct. 3, 2016 /PRNewswire/ -- OMRON Corporation announced on October 3 that it will release two variations of the Mobile Robot LD Platform, developed for indoor use by its U.S. subsidiary ...

The company will operate out of new offices in Consilium Place, a Toronto East business complex. October 29, 2015 – Omron Automation and Safety will move its Canada headquarters to new offices in ...

Adept is a U.S. based manufacturer of autonomous mobile robots, industrial robots, configurable linear modules, machine controllers, machine vision systems and software. September 16, 2015 –Omron ...